Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000083163 | SCV000244496 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2015-08-10 | reviewed by expert panel | curation | IARC class based on posterior probability from multifactorial likelihood analysis, thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000116 |
Labcorp Genetics |
RCV001084105 | SCV000073891 | benign | Hereditary breast ovarian cancer syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000083163 | SCV000220725 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2014-09-23 | criteria provided, single submitter | literature only | |
ARUP Laboratories, |
RCV000506937 | SCV000602789 | benign | not specified | 2016-10-12 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000580656 | SCV000684081 | benign | Hereditary cancer-predisposing syndrome | 2015-04-22 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000083163 | SCV000744789 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000679199 | SCV000805799 | likely benign | not provided | 2017-10-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000679199 | SCV001945437 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 21990134, 17924331) |
National Health Laboratory Service, |
RCV001084105 | SCV002025878 | benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000580656 | SCV002689052 | benign | Hereditary cancer-predisposing syndrome | 2014-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Genomic Medicine, |
RCV000506937 | SCV004027493 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Sharing Clinical Reports Project |
RCV000083163 | SCV000115237 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2012-05-01 | no assertion criteria provided | clinical testing | |
Breast Cancer Information Core |
RCV000083163 | SCV000147689 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 2002-05-29 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000083163 | SCV000733339 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000679199 | SCV001958843 | likely benign | not provided | no assertion criteria provided | clinical testing |